Cross-referencing clinical data
EarlySplit Gill Polypore Mycelium
Split Gill Polypore Mycelium.
Split Gill mushroom mycelium containing schizophyllan, a beta-glucan with some interesting immune research. Provides schizophyllan (a beta-glucan) that may activate immune cells, based primarily on injectable research
EarlyResearch strength1,000mgDaily amount
Reviewed March 2026
What Split Gill Polypore Mycelium is, and what it does.
- Does it work
- The active compound schizophyllan has real clinical data, but it was given by injection. Oral mycelium supplements are a big extrapolation from that evidence. It's speculative at best.
- How much to take
- 500-1000mg of the biomass daily. No established oral dose because the clinical research used injectable forms at very different doses.
- The first dose
- Nothing detectable. Even if the beta-glucans are bioactive orally, immune modulation takes weeks to manifest.
- With regular use
- Theoretical immune support over months. No oral supplement studies to give you a real timeline.
- How well tolerated
- Well tolerated. Schizophyllum commune is edible (it's eaten in parts of Asia and Mexico). No reported adverse effects from supplement forms.
- How it feels
- You won't feel it. This is purely a theoretical immune-support ingredient in the current oral supplement form.
About 1,000mg a day is the studied dose.
How much to take a dayLimited data
Up to 500mgA supporting amount. Helps a little, not the studied dose.
500mg to 1,000mgEnough for most people, and where a lot of good products land.
1,000mg
The doseThe daily amount the trials actually used. A product at this figure is dosed right where the research is.
Above 1,000mgMore capsules, not more effect. Rarely in a serving anyway.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Schizophyllan activates immune cells
- Oral supplements provide immune benefits
- Anti-cancer properties
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.
Questions people ask about Split Gill Polypore Mycelium.
- Is the injectable research relevant to oral supplements?
- Partially. The immune-activating mechanism is real, but injection bypasses digestion entirely. Oral beta-glucans interact with gut immune tissue differently, and the effects may be weaker.
- Why is this in my mushroom blend?
- Diversity. Multi-mushroom blends aim to provide different types of beta-glucans from different species. Split gill adds schizophyllan to the mix, which is structurally different from beta-glucans in reishi or turkey tail.
- Should I take this alone or in a blend?
- In a blend. As a standalone supplement, the evidence doesn't justify it. But as part of a multi-species mushroom stack, it adds a unique beta-glucan profile.
- How does it compare to turkey tail or reishi?
- Turkey tail (PSK/PSP) and reishi have much more oral supplement research. If you're choosing one mushroom for immune support, those are better bets. Split gill is a supporting player.
- Is the mycelium-on-rice format a problem?
- It's the same issue as other mycelium-on-grain products. A significant portion of what you're taking is rice starch, not mushroom actives. Look for beta-glucan content on the label.
- Can I eat split gill mushrooms?
- Yes, they're edible and eaten in many cultures. But they're tough and rubbery with a mild flavor. Not exactly a culinary highlight for Western palates.
Nothing to show here, and the reason why.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Split Gill Polypore Mycelium has none that clears that bar.
No pairing for Split Gill Polypore Mycelium has cleared review yet.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
Plays well withEstablished knowledge, not a trial
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Split Gill Polypore Mycelium + beta-glucan-yeastBoth are beta-1,3-glucans recognised by the same innate immune receptors, so their pattern-recognition activity overlaps rather than adds a new route.
Schizophyllan from Schizophyllum commune and yeast-derived beta-glucan share a beta-1,3-linked backbone with beta-1,6 branches. Dectin-1 and complement receptor 3 on innate immune cells bind that motif regardless of which fungus supplied it. Stacking the two raises total glucan load on one receptor system rather than opening a second one. Formulators pair them for breadth of source, not for a separate mechanism.
Split Gill Polypore Mycelium + beta-glucanSame structural class, same receptor recognition.
Generic beta-glucan preparations and schizophyllan are read by the body through the same carbohydrate-recognition machinery. Solubility and branching differ between sources, which changes how much reaches immune tissue, but the recognised motif is the same. Combined products deliver a higher glucan dose on one pathway. This is established carbohydrate immunology rather than a tested combination.
Split Gill Polypore Mycelium + reishiBoth are fungal polysaccharide sources used together in traditional mushroom blends.
Reishi contributes its own beta-glucan fraction alongside triterpenes that schizophyllan preparations do not carry. Blends are built for a wider polysaccharide profile across species. The pairing is formulation convention with a shared structural rationale, not a measured combination effect.
Split Gill Polypore Mycelium + turkey-tailTurkey tail supplies protein-bound polysaccharides that overlap in receptor class with schizophyllan.
Both fungi are cultivated for their cell-wall polysaccharide fractions. The immune-cell receptors involved read the glucan backbone common to each. A blend increases total recognised polysaccharide rather than introducing a distinct target. Read it as mechanistic overlap rather than tested synergy.
Split Gill Polypore Mycelium + maitakeAnother beta-glucan-bearing basidiomycete used in the same blends.
Maitake's glucan fraction differs in branching frequency from schizophyllan, which changes solubility and viscosity. Both are recognised by the same innate receptor set. Multi-mushroom formulas combine them for source diversity. No combination trial grounds this pairing.
Split Gill Polypore Mycelium + vitamin-d3Vitamin D receptor signalling modulates innate immune cell responsiveness to microbial pattern recognition.
Monocytes and macrophages express the vitamin D receptor, and receptor occupancy shifts how those cells respond after pattern-recognition receptors are engaged. Schizophyllan acts at the recognition step; vitamin D acts on the cell's downstream readiness. The two touch normal immune signalling at different points. This is receptor biology, not a measured clinical pairing.
Split Gill Polypore Mycelium + zincZinc is a required cofactor for the enzymes and transcription factors innate immune cells depend on.
Zinc-dependent enzymes and zinc-finger transcription factors sit throughout normal immune cell function. A glucan that engages a receptor still needs the downstream machinery intact. Adequate zinc status supports that machinery. The relationship is nutritional dependence rather than a combination effect.
Split Gill Polypore Mycelium + probioticsFungal beta-glucans reach the colon undigested and are available to resident bacteria.
Human digestive enzymes do not cleave beta-1,3 glucosidic bonds, so a substantial fraction of ingested schizophyllan arrives intact in the large bowel. Several commensal genera ferment glucans there. Co-supplying live cultures gives the substrate an organism to reach. Extent of fermentation varies with the individual's existing microbial community.
Split Gill Polypore Mycelium + inulinTwo distinct fermentable substrates reaching the same colonic compartment.
Inulin is a fructan fermented rapidly in the proximal colon; fungal beta-glucan ferments more slowly and further along. Combining them spreads fermentable substrate across the length of the bowel. Both raise short-chain fatty acid production by resident bacteria. Gas and bloating scale with total fermentable load, so the combination is dose-sensitive.
Split Gill Polypore Mycelium + butyrateButyrate is an end product of the colonic fermentation that beta-glucan feeds.
Bacterial fermentation of glucans yields short-chain fatty acids, butyrate among them, which colonocytes use as a fuel. Supplying butyrate directly and supplying its substrate are two routes to the same molecule in the lumen. The pairing is mechanistically coherent rather than trial-tested.
Split Gill Polypore Mycelium + resistant-starchBoth are non-digestible polysaccharides fermented by colonic bacteria.
Resistant starch and fungal beta-glucan pass the small intestine largely intact and are fermented by different bacterial groups. Together they broaden which organisms are fed. Total fermentable load determines tolerability more than either ingredient alone.
Split Gill Polypore Mycelium + vitamin-cAscorbate supports normal innate immune cell function that a glucan preparation engages.
Neutrophils concentrate ascorbate well above plasma levels and use it during normal oxidative activity. A beta-glucan that engages those cells depends on their baseline function being intact. This is nutrient adequacy supporting a pathway, not an ingredient interaction.
Split Gill Polypore Mycelium + seleniumSelenoproteins handle the peroxide load generated during normal immune cell activity.
Glutathione peroxidases and thioredoxin reductases are selenoenzymes that manage reactive oxygen species produced by activated phagocytes. Adequate selenium keeps that handling intact. The link to schizophyllan is that both touch the same cell population from different sides.
Who should be cautious
Talk to a doctor before taking Split Gill Polypore Mycelium if any of these apply to you: Most research is on injectable schizophyllan, not oral, Mycelium on grain reduces potency, Oral bioavailability of schizophyllan is unclear. These are flags to check first, not effects Split Gill Polypore Mycelium is known to cause.
Not medical advice. Show the label to your pharmacist.Getting Split Gill Polypore Mycelium from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
Dried split gill mushroom
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
Mycelial biomass powderDried, milled fungal mycelium together with the colonised rice substrate; beta-glucan sits in the fungal cell wall alongside grain starch and protein.Fits Formulas that want the whole cultivated material and state the biomass weight rather than a polysaccharide figure.Trade-off Glucan content is diluted by residual substrate and varies with how far colonisation ran, so the label weight is not a polysaccharide weight.
Hot-water extracted polysaccharide fractionWater-soluble fraction pulled from the biomass under heat, concentrating schizophyllan and related glucans away from insoluble substrate residue.Fits Formulas that declare a beta-glucan percentage and want a defined polysaccharide input.Trade-off Extraction discards the water-insoluble fraction and the non-polysaccharide constituents of the mycelium, and heat can alter the triple-helical conformation.
Isolated schizophyllanPolysaccharide purified further from the extract, characterised by molecular weight and glucan assay.Fits Applications needing a defined molecular species with batch-to-batch consistency.Trade-off Highest processing burden and the narrowest composition; anything in the biomass other than the isolated polysaccharide is gone.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
